Jack H. Dean
CIK: 0001434978
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACXP
Acurx Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About DEAN JACK H
DEAN JACK H (SEC CIK 0001434978) files insider reports with the SEC as Director of Acurx Pharmaceuticals, Inc. (ACXP).
Signal8 holds 2 ownership filings by DEAN JACK H, all Form 4s, filed between Jan 8, 2025 and Apr 22, 2026. Those filings report 2 transactions, from Jan 6, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DEAN JACK H's filings is in STATEN ISLAND, NY.
Recent filings by DEAN JACK H
Other insiders filing for Acurx Pharmaceuticals, Inc. (ACXP)
- Sailer Carl, Director
- Donohue James J., Director
- HARRISON THOMAS L, Director
- Scodari Joseph C, Director
- DELUCCIA ROBERT J, Director
- LUCI DAVID P, President and CEO